Filing Details
- Accession Number:
- 0001062993-16-009882
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-19 11:42:03
- Reporting Period:
- 2016-05-18
- Filing Date:
- 2016-05-19
- Accepted Time:
- 2016-05-19 11:42:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1355189 | Thomas Wegman | C/O Biospecifics Technologies Corp., 35 Wilbur Street Lynbrook NY 11563 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 50 | $33.80 | 1,005,128 | No | 4 | S | Indirect | See footnote |
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 150 | $34.14 | 1,004,978 | No | 4 | S | Indirect | See footnote |
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 50 | $34.11 | 1,004,928 | No | 4 | S | Indirect | See footnote |
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 24,750 | $33.00 | 980,178 | No | 4 | S | Indirect | See footnote |
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 50 | $33.80 | 220,772 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 150 | $34.14 | 220,622 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 50 | $34.11 | 220,572 | No | 4 | S | Direct | |
| Common Stock, $0.001 Par Value | Disposition | 2016-05-18 | 24,750 | $33.00 | 195,822 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The selling price of $33.80 is reflective of the sale price of all transactions reported on this line.
- The selling price of $34.14 is reflective of the sale price of all transactions reported on this line.
- The selling price of $34.11 is reflective of the sale price of all transactions reported on this line.
- The selling price of $33.00 is reflective of the sale price of all transactions reported on this line.
- These shares are held in trust on behalf of the reporting person and Mrs. Toby Wegman. The reporting person is the co-trustee of the trust with Ms. Toby Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
- The selling price of $33.80 is reflective of the sale price of all transactions reported on this line.
- The selling price of $34.14 is reflective of the sale price of all transactions reported on this line.
- The selling price of $34.11 is reflective of the sale price of all transactions reported on this line.
- The selling price of $33.00 is reflective of the sale price of all transactions reported on this line.
Billionaire Hedge Funds
